Literature DB >> 8690560

Health status index models for use in resource allocation decisions. A critical review in the light of observed preferences for social choice.

E Nord1.   

Abstract

In the last two decades a number of health status index models have been developed for assessing the value of health outcomes in terms of quality-adjusted life years. The models can be tested by comparing their implications with direct observations of how societies think resources should be distributed across patient groups. This paper reviews empirical evidence of this kind from various countries and summarizes the evidence in three rules of thumb for selecting values for health states. Nine different models are judged relative to these rules of thumb. Eight of the models underestimate the strength of social preferences for treating the severely ill before the less severely ill. The ninth has a strong bias against states associated with emotional distress. As a consequence, none of the models can be seen as sufficient stand-alone instruments for valuing health outcomes. Instead, the models may be seen as complementary and adjustable parts of a tool kit that should also include the rules of thumb suggested in this paper.

Entities:  

Mesh:

Year:  1996        PMID: 8690560     DOI: 10.1017/s0266462300009363

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  8 in total

1.  Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease.

Authors:  K Stavem
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

2.  Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications.

Authors:  J Hahl; H Hämäläinen; H Sintonen; T Simell; S Arinen; O Simell
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

Review 3.  Willingness to pay for a QALY: theoretical and methodological issues.

Authors:  Dorte Gyrd-Hansen
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Towards cost-value analysis in health care?

Authors:  E Nord
Journal:  Health Care Anal       Date:  1999

5.  Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS.

Authors:  Knut Stavem; Stig S Frøland; Kjell B Hellum
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

6.  A methodological guide to performing a cost-utility study comparing surgical techniques.

Authors:  Achilleas Thoma; Ted Haines; Karen Veltri; Charlie H Goldsmith; Bernie J O'Brien; Caroline Quartly
Journal:  Can J Plast Surg       Date:  2004

7.  Theory of constraints for publicly funded health systems.

Authors:  Somayeh Sadat; Michael W Carter; Brian Golden
Journal:  Health Care Manag Sci       Date:  2012-08-21

8.  Cost-utility analysis of melphalan plus prednisone with or without interferon-alpha 2b in newly diagnosed multiple myeloma. Results from a randomised controlled trial.

Authors:  E Nord; F Wisløff; M Hjorth; J Westin
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.